- BPMC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
Blueprint Medicines (BPMC) 8-K8 Sep 20Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the TreatmentFinancial data
Company Profile